Carles Pericay

Phase II, Randomized Study of Concomitant Chemoradiotherapy Followed by Surgery and Adjuvant Capecitabine Plus Oxaliplatin (CAPOX) Compared With Induction CAPOX Followed by Concomitant Chemoradiotherapy and Surgery in Magnetic Resonance Imaging–Defined, Locally Advanced Rectal Cancer: Grupo Cáncer de Recto 3 Study

Carlos Fernández-Martos, Carles Pericay, Jorge Aparicio et al. · Journal of Clinical Oncology · 2010 · 428 citations · Full text

Adaptive Radiotherapy, Recto 3, Radiation Medicine +15

Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial

Carlos Fernández-Martos, Xabier García‐Albéniz, Carles Pericay et al. · Annals of Oncology · 2015 · 352 citations · Full text

Surgical Oncology, Radiation Therapy, Medicine +6

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

Xavier García del Muro, Antonio López–Pousa, Joan Maurel et al. · Journal of Clinical Oncology · 2011 · 293 citations

microRNA expression profile in stage III colorectal cancer: Circulating miR-18a and miR-29a as promising biomarkers

Anna Brunet Vega, Carles Pericay, Irene Moya et al. · Oncology Reports · 2013 · 162 citations

Addition of Bevacizumab to XELOX Induction Therapy Plus Concomitant Capecitabine-Based Chemoradiotherapy in Magnetic Resonance Imaging–Defined Poor-Prognosis Locally Advanced Rectal Cancer: The AVACROSS Study

Miguel Nogué, Antonieta Salud, Pilar Vicente et al. · The Oncologist · 2011 · 154 citations · Full text